RADICAVA ORS® (edaravone) | Treatment & Support

MENU

MENU

Get the information you need on your treatment journey.

GO TO THE JOURNEY GUIDE

TBD

RADICAVA ORS^® is on the VA National Formulary

TBD

The RADICAVA ORS^® Educational Communication Series

How Treatment Can Help

How Treatment Can Help

REVIEW THE DATA

Learn how RADICAVA ORS^® was proven to help slow the loss of physical function by 33% at 24 weeks.

REVIEW THE DATA

Fitting Your Routine

Fitting Your Routine

See how RADICAVA ORS^® can
fit your routine with a
5 mL oral dose of a proven treatment.^{a,b (see footnote)}

Getting Started

Getting Started

Review how to start RADICAVA ORS^®, questions to ask your doctor, financial support options, and more.

No matter where you are in your ALS journey—from diagnosis to treatment—the JourneyMate Support Program^™ gives you the understanding, answers, and resources to help you move forward. If you’re new to treatment, the program can help you learn more about RADICAVA ORS^®.

The RADICAVA ORS^® Educational Communications Series—Sign Up Today

Join our community of 18,000+ people who’ve signed up to learn more about RADICAVA ORS^® and why it matters to patients and caregivers.

LEARN MORE & SIGN UP

Help other people living with ALS by sharing your experience with ALS and RADICAVA ORS^®. See how you can share

^aThe initial treatment cycle starts with daily dosing of RADICAVA ORS^® for 14 days followed by a 14-day drug-free period. Subsequent treatment cycles include daily dosing 10 out of 14 days followed by a 14-day drug-free period. Return to content

^bUse the provided 5 mL syringe that comes with the product. Do not use a household teaspoon to measure your medication. Return to content

Important Safety Information

Do not receive RADICAVA ORS^® (edaravone) if you are allergic to edaravone or any of the ingredients in RADICAVA ORS.

Before you take RADICAVA ORS, tell your healthcare provider about all of your medical conditions, including if you:

have asthma.
are allergic to other medicines.
are pregnant or plan to become pregnant. It is not known if RADICAVA ORS will harm your unborn baby.
are breastfeeding or plan to breastfeed. It is not known if RADICAVA ORS passes into your breastmilk. You and your healthcare provider should decide if you will receive RADICAVA ORS or breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of RADICAVA ORS?

RADICAVA ORS may cause serious side effects, including hypersensitivity (allergic) reactions and sulfite allergic reactions.

Hypersensitivity reactions have happened in people taking RADICAVA ORS and can happen after your medicine has been taken.
RADICAVA ORS contains sodium bisulfite, a sulfite that may cause a type of allergic reaction that can be serious and life-threatening. Sodium bisulfite can also cause less severe asthma episodes in certain people. Sulfite sensitivity can happen more often in people who have asthma than in people who do not have asthma.
Tell your healthcare provider right away or go to the nearest emergency room if you have any of the following symptoms: hives; swelling of the lips, tongue, or face; fainting; breathing problems; wheezing; trouble swallowing; dizziness; itching; or an asthma attack (in people with asthma).

Your healthcare provider will monitor you during treatment to watch for signs and symptoms of all the serious side effects and allergic reactions.

Common side eﬀects reported include bruising (contusion), problems walking (gait disturbance), headache and fatigue. These are not all the possible side eﬀects of RADICAVA ORS.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to www.fda.gov/medwatch or Tanabe Pharma America, Inc. at 1-888-292-0058.

INDICATION

RADICAVA ORS^® (edaravone) is indicated for the treatment of amyotrophic lateral sclerosis (ALS).

Please see the full Prescribing Information and Patient Information, also available at www.radicavaors.com.

RADICAVA, RADICAVA ORS, and the RADICAVA ORS logo are registered trademarks of K.K. BCJ-94. The corporate symbol of Tanabe Pharma America is a registered trademark of Tanabe Pharma Corporation.

JourneyMate Support Program is a trademark of Tanabe Pharma America, Inc.

All other trademarks are the property of their respective owners.

Intended for US Residents Only.

© 2025 Tanabe Pharma America, Inc. All rights reserved. CP-OE-US-1241 12/25

You are now leaving Radicava.com

You are leaving this website, hosted by Tanabe Pharma America.
This link may take you to a website to which our Privacy Policy does not apply.
Tanabe Pharma America does not control the content of third-party sites.